MYZAP 抗体 (N-Term)
Quick Overview for MYZAP 抗体 (N-Term) (ABIN4889364)
抗原
See all MYZAP 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- N-Term
- 
                                            特异性
- Reacts with all isoforms of human MYZAP
- 
                                            纯化方法
- Purified (protein A)
- 
                                            免疫原
- Synthetic peptide derived from N terminal part of human MYZAP
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 
                        Working dilution: Optimal dilution should be determined by the end user. 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Lyophilized
- 
                                            溶解方式
- Must be reconstituted in distilled water.
- 
                                            浓度
- 1 mg/mL
- 
                                            缓冲液
- Tris 0,1M, glycine 0,1M, sucrose 2 %
- 
                                            储存条件
- 4 °C/-20 °C
- 
                                            储存方法
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 months from date of receipt.
- 
                                            有效期
- 24 months
 
- 
                                            
- 
    - MYZAP (Myocardial Zonula Adherens Protein (MYZAP))
- 
                                            别名
- MYZAP
- 
                                            背景
- MYZAP is expressed in cardiac tissue and is involved in cellular signaling.
- 
                                            基因ID
- 100820829
- 
                                            UniProt
- P0CAP1
 抗原
- 
                    
 
                                     
                                     
                                    